ES2062086T3 - Nuevos derivados de leucotrieno-b4, procedimientos para su preparacion y su utilizacion como medicamentos. - Google Patents

Nuevos derivados de leucotrieno-b4, procedimientos para su preparacion y su utilizacion como medicamentos.

Info

Publication number
ES2062086T3
ES2062086T3 ES89730124T ES89730124T ES2062086T3 ES 2062086 T3 ES2062086 T3 ES 2062086T3 ES 89730124 T ES89730124 T ES 89730124T ES 89730124 T ES89730124 T ES 89730124T ES 2062086 T3 ES2062086 T3 ES 2062086T3
Authority
ES
Spain
Prior art keywords
residue
group
hydrogen atom
derivates
atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89730124T
Other languages
English (en)
Inventor
Werner Skuballa
Bernd Buchmann
Wolfgang Frohlich
Roland Ekerdt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2062086T3 publication Critical patent/ES2062086T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/28—Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings
    • C07C33/30—Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/14—Preparation of carboxylic acid esters from carboxylic acid halides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/29—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by introduction of oxygen-containing functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/297—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE PATENTE ABARCA DERIVADOS DE LEUCOTRIENO-B4 DE FORMULA I, DONDE R1 REPRESENTA EL RESTO CH2OH, EL RESTO COOR5 O EL RESTO CONHR6; A ES UN GRUPO TRANS,TRANS - CH = CH - CH = CH O TETRAMETILENO, B ES UN GRUPO ALQUILENO CON HASTA 10 ATOMOS DE CARBONO, DE CADENA SIMPLE O COMPLEJA, SATURADO O NO; D ES UN ENLACE DIRECTO, OXIGENO, AZUFRE, UN GRUPO - C (EQUIVALE) C - O UN GRUPO CH = CR7, B Y D JUNTOS SON UN ENLACE DIRECTO; R2 Y R3 PUEDEN SER IGUALES O DISTINTOS, Y REPRESENTAN UN ATOMO DE HIDROGENO O UN RESTO ACIDO DE UN ACIDO ORGANICO CON 1-15 ATOMOS DE CARBONO; Y R4 ES UN ATOMO DE HIDROGENO, UN RESTO ALQUILO, UN RESTO CICLOALQUILO, UN RESTO ARILO O UN RESTO HETEROCICLICO DE 5 O 6 MIEMBROS EN EL CASO DE QUE R5 SEA UN ATOMO DE HIDROGENO. TAMBIEN ABARCA LAS SALES DE ESTOS COMPUESTOS CON BASES FISIOLOGICAMENTE COMPATIBLES Y SUS CICLODEXTRINCLATRATOS, TAMBIEN EL PROCESO PARA SU OBTENCION Y SU USO COMO MEDICAMENTO.
ES89730124T 1988-05-19 1989-05-19 Nuevos derivados de leucotrieno-b4, procedimientos para su preparacion y su utilizacion como medicamentos. Expired - Lifetime ES2062086T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3817385A DE3817385A1 (de) 1988-05-19 1988-05-19 Neue leukotrien-b(pfeil abwaerts)4(pfeil abwaerts)-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
ES2062086T3 true ES2062086T3 (es) 1994-12-16

Family

ID=6354874

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89730124T Expired - Lifetime ES2062086T3 (es) 1988-05-19 1989-05-19 Nuevos derivados de leucotrieno-b4, procedimientos para su preparacion y su utilizacion como medicamentos.

Country Status (12)

Country Link
EP (1) EP0344096B1 (es)
JP (1) JPH03505326A (es)
AT (1) ATE99663T1 (es)
AU (1) AU3733489A (es)
DE (2) DE3817385A1 (es)
DK (1) DK275390A (es)
ES (1) ES2062086T3 (es)
HU (1) HUT54605A (es)
IE (1) IE66678B1 (es)
IL (1) IL90351A0 (es)
WO (1) WO1989011469A1 (es)
ZA (1) ZA893795B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988005045A1 (en) * 1986-12-29 1988-07-14 The Upjohn Company Leukotriene b4 analogs
DE4009117A1 (de) * 1990-03-19 1991-09-26 Schering Ag Neue leukotrien-b(pfeil abwaerts)4(pfeil abwaerts)-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US6342525B1 (en) * 1999-11-09 2002-01-29 Alcon Universal Ltd. Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders
JP4807549B2 (ja) * 2003-02-28 2011-11-02 克彦 友岡 シロキサン類，シラノール類及びシラン類，並びにその製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0296580B1 (en) * 1987-06-26 1992-11-11 G.D. Searle & Co. Phenylene, furyl, and thienyl leukotriene b4 analogues
US4855324A (en) * 1987-12-08 1989-08-08 G. D. Searle & Co. Furyl, phenylene, and thienyl leukotriene B4 analogues

Also Published As

Publication number Publication date
WO1989011469A1 (en) 1989-11-30
IE66678B1 (en) 1996-01-24
IL90351A0 (en) 1989-12-15
HU893626D0 (en) 1991-01-28
IE891626L (en) 1989-11-19
EP0344096B1 (de) 1994-01-05
DK275390D0 (da) 1990-11-19
AU3733489A (en) 1989-12-12
JPH03505326A (ja) 1991-11-21
HUT54605A (en) 1991-03-28
DE3817385A1 (de) 1989-11-30
ZA893795B (en) 1990-11-28
DK275390A (da) 1990-11-19
DE58906619D1 (de) 1994-02-17
ATE99663T1 (de) 1994-01-15
EP0344096A1 (de) 1989-11-29

Similar Documents

Publication Publication Date Title
ES2111654T3 (es) Derivados de piperazina como antagonistas de 5-ht1a.
DE3786843D1 (de) Chinolincarbonsaeurederivate.
IE40068L (en) 1, 4- dihydro -h- isoquinolines
ES2062086T3 (es) Nuevos derivados de leucotrieno-b4, procedimientos para su preparacion y su utilizacion como medicamentos.
HUT45400A (en) Process for production of medical compositions containing derivatives of propiophenone
ES488988A0 (es) Un metodo de preparar derivados de fenil-piperazina farma- ceuticamente activos
MY102921A (en) Amino-alcohol derivatives and processes for their preparation.
FI853233L (fi) 1,6-naftyridinderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter.
ATE58532T1 (de) (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung.
ES542393A0 (es) "4-(nitrofenil)-tetrahidropiridinas,procedimiento para su obtencion y su empleo como medicamento"
ATE78689T1 (de) Verwendung von -7-thiaprostaglandin e1 oder seinen derivaten zur herstellung eines antidiabetikums.
DE3688161D1 (de) Gegebenenfalls etherifizierte oder esterifizierte in stellung 2 substituierte 4-oh-chinolincarbonsaeurederivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
FR2390954A1 (fr) Nouvelles guanylhydrazones, leurs procedes de preparation et medicaments les contenant
ES2031457T3 (es) Derivados de 5-aminialquil-beta-carbolina, a su preparacion y a su utilizacion como medicamentos.
JPS5533476A (en) Novel alphaaaminophenylacetic acid derivative
SE7905631L (sv) Nya oxotiaforeningar
ES375396A1 (es) Un procedimiento para la preparacion de nuevos acidos epo- xietilfosfonicos.
ATE107296T1 (de) Optisch aktive piperazin-derivate.
DE68912745D1 (de) Herstellung von optisch aktiven 2-Oxoimidazolidin-derivaten.
TH2445A (th) ไพริมิดีนที่ถูกแทนที่
ATE1585T1 (de) Clavulansaeurederivate, ihre herstellung und sie enthaltende pharmazeutische praeparate.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 344096

Country of ref document: ES